• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYC
Click for more information
3.89% $1.73

CYCLOPHARM LIMITED - Charts / Financials

Market Cap $162.9M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Cyclopharm Limited is an Australia-based health technology company. The Company’s... Cyclopharm Limited is an Australia-based health technology company. The Company’s principal activity is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector. Its segments include Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The Company distributes its products in approximately 60 countries throughout the world with over 1500 nuclear medicine departments utilizing Technegas. Its subsidiaries include Cyclomedica Europe Limited, Cyclomedica Australia Pty Limited and Cyclomedica Canada Limited.More

refresh Created with Sketch. REFRESH
Last update - 13.36pm 06/05/2024 (20 minute delay) ?
Day
Open $1.80   Day High $1.80   Day Low $1.73
Daily Volume 32866
Bids   Sellers
Number Price Volume   Number Price Volume
2 $1.73 9499   2 $1.80 6189

Directors & Senior Management

Mr. James M. Mcbrayer Chief Executive Officer, Managing Director, Executive Director, Company Secretary
Mr. Jason Smith Chief Financial Officer
Mr. Mathew Farag Chief Operating Officer
Mr. David James Heaney Independent Non-Executive Chairman of the Board
Mr. John Wigglesworth Non-Executive Director
Ms. Dianne Margaret Angus Non-Executive Independent Director
Mr. Kevin Barrow Non-Executive Independent Director
Prof. Dr. Gregory George King Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
$1.73 		Change
-0.070(3.89%) 		Mkt cap ! $162.9M
Open High Low Value Volume
$1.80 $1.80 $1.73 $57.22K 32.86K

Buyers (Bids)

No. Vol. Price($)
2 9499 $1.73
 

Sellers (Offers)

Price($) Vol. No.
$1.80 6189 2
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
$1.75 		  Change
-0.070 ( 1.69 %)
Open High Low Volume
$1.75 $1.76 $1.75 946
Last updated 13.36pm 06/05/2024 ?

Top Stories

Mantle Minerals to kick off drilling at Mt Berghaus in WA

Mantle Minerals (ASX:MTL) has announced it's kicking off a 122-hole drill run on-site its Mt Berghaus acreage in Western Australia.
Maiden drilling at West Arunta hints at major IOCG system for Rincon Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.
Sold out signs go up for RIU Resources Roundup in Sydney More than 115 companies will be participating in this year's RIU Resources Roundup in Sydney.
Tamboran is listing on the NYSE, and Wall Street is paying attention If you needed evidence that Tamboran Resources is bullish on the NT's Beetaloo Basin, look no further than its decision to list on the NYSE.
Westpac tracks lower in profits in first half of 2024, with a 16% yoy drop amid slowing economy Westpac Banking Corporation has reported a 16 percent drop in net profit (to $3.342 billion) for the first half of the 2024 financial year compared to the same time last year.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.